Literature DB >> 1629614

A modified colorimetric method for the measurement of phagocytosis and antibody-dependent cell cytotoxicity using 2,7-diaminofluorene.

S J Gebran1, E L Romano, H A Pons, L Cariani, A N Soyano.   

Abstract

A sensitive and rapid colorimetric method for the in vitro determination of phagocytic activity and antibody-dependent cell-mediated cytotoxicity (ADCC) is described. The assay uses red blood cells (RBC) as target cells and relies on the specific oxidation of 2,7-diaminofluorene (DAF) by the pseudoperoxidase activity of hemoglobin (Hb). Generation of fluorene blue (FB), the chromophore formed upon oxidation of DAF, was a linear function of erythrocyte concentration. The oxidation of DAF by peritoneal macrophages (M phi) containing myeloperoxidase was negligible, confirming that the development of color was exclusively due to the pseudoperoxidase activity of Hb. A positive correlation was observed between FB formation and increased phagocytosis of opsonized erythrocytes. Phagocytosis increased as a function of time, reaching a maximum at 90 min of incubation. The phagocytosis of IgG-opsonized erythrocytes was greater than non-opsonized erythrocytes and was inhibited by high concentrations of non-specific human or mouse IgG, showing that phagocytosis was mediated by the Fc gamma receptor of macrophages. The interaction between opsonized RBC and macrophages also evoked an antibody-dependent extracellular lysis, however this process was slower than ingestion. The DAF phagocytosis assay has shown to be very sensitive, simple, rapid and safe.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629614     DOI: 10.1016/0022-1759(92)90125-d

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  A role for activated endothelial cells in red blood cell clearance: implications for vasopathology.

Authors:  Marcel H A M Fens; Richard van Wijk; Grietje Andringa; Karlijn L van Rooijen; Hilde M Dijstelbloem; Jan T Rasmussen; Karen M K de Vooght; Raymond M Schiffelers; Carlo A J M Gaillard; Wouter W van Solinge
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

2.  Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies.

Authors:  Dylana Díaz-Solano; Jaheli Fuenmayor; Ramon F Montaño
Journal:  Blood Transfus       Date:  2017-05-30       Impact factor: 3.443

3.  Solid and liquid state characterization of tetrahydrocurcumin using XRPD, FT-IR, DSC, TGA, LC-MS, GC-MS, and NMR and its biological activities.

Authors:  Mahendra Kumar Trivedi; Parthasarathi Panda; Kalyan Kumar Sethi; Mayank Gangwar; Sambhu Charan Mondal; Snehasis Jana
Journal:  J Pharm Anal       Date:  2020-02-15

Review 4.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

5.  Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy.

Authors:  Gaoqian Feng; Elizabeth Aitken; Francisca Yosaatmadja; Linda Kalilani; Steven R Meshnick; Anthony Jaworowski; Julie A Simpson; Stephen J Rogerson
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

6.  Brain Endothelial Erythrophagocytosis and Hemoglobin Transmigration Across Brain Endothelium: Implications for Pathogenesis of Cerebral Microbleeds.

Authors:  Rudy Chang; Juan Castillo; Alexander C Zambon; Tatiana B Krasieva; Mark J Fisher; Rachita K Sumbria
Journal:  Front Cell Neurosci       Date:  2018-09-06       Impact factor: 5.505

7.  Quantitative analysis of red blood cell membrane phospholipids and modulation of cell-macrophage interactions using cyclodextrins.

Authors:  Amid Vahedi; Parnian Bigdelou; Amir M Farnoud
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.